EIF3L and breast ductal adenocarcinoma: The same trend of EIF3L was observed in Mucinous Breast Carcinoma (P < 0.001, fold change = −2.208), Invasive Ductal Breast Carcinoma (P < 0.001, fold change = −2.112) according to the data from TCGA, as well as in ductal breast carcinoma (P < 0.001, fold change = −2.071) based on the data from the study of Richardson et al [33].